Lewis Stuart
Overview
Lewis Stuart received $2M in total compensation, including $258K in salary, at Cymabay Therapeutics in 2021. Lewis Stuart also received an average of $257K at NovaBay Pharmaceuticals between 2017 and 2018.
Source: SEC filings on April 26, 2022, April 19, 2019, and April 18, 2018.
Related executives
We found 21 more executives who work or worked at Cymabay Therapeutics and NovaBay Pharmaceuticals.
Sujal Shah
Cymabay Therapeutics
Chief Executive Officer
Charles McWherter
Cymabay Therapeutics
President of R&D
Paul Quinlan
Cymabay Therapeutics
General Counsel
Dennis Kim
Cymabay Therapeutics
Chief Medical Officer
Justin Hall
NovaBay Pharmaceuticals
Chief Executive Officer
Andrew Jones
NovaBay Pharmaceuticals
Chief Financial Officer
Audrey Kunin
NovaBay Pharmaceuticals
Chief Product Officer
Wang Xu
NovaBay Pharmaceuticals